MGAT5 drives melanoma aggressiveness via TIMP1 glycosylation–dependent CD63–β1-integrin signaling
Translational Research
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицинская биохимия»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
MGAT5 drives melanoma aggressiveness via TIMP1 glycosylation–dependent CD63–β1-integrin signaling. // Translational Research. – URL: https://www.sciencedirect.com/science/article/pii/S1931524426001969?dgcid=rss_sd_all
MGAT5 drives melanoma aggressiveness via TIMP1 glycosylation–dependent CD63–β1-integrin signaling. Translational Research. https://www.sciencedirect.com/science/article/pii/S1931524426001969?dgcid=rss_sd_all
“MGAT5 drives melanoma aggressiveness via TIMP1 glycosylation–dependent CD63–β1-integrin signaling.” Translational Research.
@article{article70210,
title = {MGAT5 drives melanoma aggressiveness via TIMP1 glycosylation–dependent CD63–β1-integrin signaling},
journal = {Translational Research},
url = {https://www.sciencedirect.com/science/article/pii/S1931524426001969?dgcid=rss_sd_all}
}